JWG-071

DL-071-IT

TAK-071

Luseogliflozin

Butanedioic acid, sulfo-, 4-[2-[(2-hydroxyethyl)amino]ethyl] ester, N-coco acyl derivs., disodium salts

Chromate(3-), [4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)][3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)]-, trisodium

hydrogen bis[2-chloro-5-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-N-methylbenzenesulphonamidato(2-)]cobaltate(1-) , compound with cyclohexylamine (1:1)

4-[4-(1H-pyrazol-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid ethyl ester

1-{2-[3-(Propan-2-yl)phenyl]ethyl}piperazine

2-[1-(aminomethyl)cyclohexyl]-N,N-dimethylaniline

N-[3-(5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]prop-2-enamide

1-(4-fluoro-1H-indol-3-yl)cyclobutane-1-carboxylic acid

2-[1-(Aminomethyl)cyclohexyl]-4,5-dimethylphenol

(1-{5H,6H,7H,8H-imidazo[1,2-a]pyridin-2-yl}cyclohexyl)methanamine

Cyclobutanecarboxylic acid, 1-(2-methoxy-4,6-dimethylphenyl)-

1-(2-Hydroxy-4,5-dimethylphenyl)cyclopentane-1-carboxylic acid

(R)-2-Amino-2-(4-(piperidin-1-YL)phenyl)acetic acid hydrochloride